학술논문

Progression of histological lesions after ABO incompatible kidney transplantation
Document Type
article
Source
Frontiers in Immunology, Vol 13 (2022)
Subject
ABOi
ABO incompatible
histological evaluation
long - term effect
rejection
chronic antibody-mediated rejection (cABMR)
Immunologic diseases. Allergy
RC581-607
Language
English
ISSN
1664-3224
Abstract
Recent large meta-analyses suggested a poorer long-term patients’ and grafts’ outcomes after ABO incompatible (ABOi) living-donor kidney transplantation (LDKT) compared to ABO compatible LDKT. However, little is known about the long-term histological pattern after ABOi LDKT. We compared the histological features observed on protocol biopsies from 03/11 to 11/19 in 94 ABOi LDKT (including 14 with preformed Donor Specific Antibodies, pDSAs), 27 LDKT ABO compatible (ABOc) with pDSAs, and 21 ABOc without pDSAs) during the first five years post transplantation. During the first 5 years post-transplantation, a progression of chronic lesions (patients with a ci >0 raised from 11% to 65%, p0 raised from 29% to 78%, p